Trust Score calculated by AI analyzing study rigor, sample size (n), and the scientific source impact factor.
Probiotic Bifidobacterium pseudocatenulatum converts hesperidin to hesperetin, activating CISD2 and reversing age‑related metabolic decline in mice
Summary
“Six‑month probiotic‑derived hesperetin treatment reduced body weight and adiposity while improving glucose tolerance, insulin sensitivity, lean mass, and muscle strength in aging mice”
Adrian Castro created Biohacker Age to have a place to closely follow longevity and biological optimization research without relying on sensationalist headlines. Content is produced with AI assistance from scientific literature and is editorially reviewed before publishing.
About our methodology →The Finding
Shen and colleagues at the Department of Life Sciences and Institute of Genome Sciences demonstrated in a controlled dietary intervention that a probiotic strain, Bifidobacterium pseudocatenulatum CL256B, achieved ~90% bioconversion of hesperidin to hesperetin and, after six months, reversed multiple age‑related metabolic deficits in naturally aging mice (sample size not disclosed in the abstract).
How They Got There
The study employed a probiotic‑assisted feeding protocol in aged mice fed a Western diet. Mice received either the probiotic‑derived hesperetin or a control diet without the engineered strain. Primary outcomes included body composition, muscle function, liver histology, and systemic glucose handling.
| Measured Variable | Outcome with Probiotic‑Derived Hesperetin |
|---|---|
| Bioconversion efficiency (hesperidin → hesperetin) | ~90% |
| Body weight & adiposity | Reduced compared with control |
| Lean mass | Increased |
| Grip strength | Enhanced |
| Hepatic steatosis | Attenuated |
| Glucose tolerance | Improved |
| Insulin sensitivity | Improved |
| Whole‑body energy metabolism | Elevated |
The Mechanism: What Happens Biologically
The probiotic expresses coordinated α‑L‑rhamnosidase and β‑glucosidase activities that cleave the glycosidic bond of hesperidin, liberating hesperetin. Hesperetin then activates CDGSH iron‑sulfur domain 2 (CISD2), a gene whose expression wanes with age and is linked to mitochondrial integrity and cellular stress resistance. Transcriptomic profiling revealed downstream activation of SIRT1 and HNF4α pathways in the liver, promoting lipid oxidation and gluconeogenic balance, while skeletal muscle showed restored ribosome homeostasis, supporting protein synthesis and muscle maintenance.
Study Limitations
- Sample size is not reported, limiting statistical power assessment.
- Findings derive exclusively from a murine model; human physiology may respond differently.
- Six‑month exposure reflects a chronic intervention; short‑term effects remain unknown.
Practical Application
It is too early to apply this probiotic‑hesperetin strategy to a personal health protocol. Human trials confirming safety, optimal dosing, and efficacy in older adults are required before actionable recommendations can be made.
Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.
Legal Notice
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or supplementation.
Science in your inbox
The most relevant studies of the week, curated and analyzed.
No spam. Unsubscribe anytime.